期刊文献+

高效液相色谱法测定伏立诺他的含量及有关物质 被引量:2

Determination of Content and Related Substances of Vorinostat by High Performance Liquid Chromatography
暂未订购
导出
摘要 目的建立测定伏立诺他含量及有关物质的高效液相色谱法。方法采用Luna-C18色谱柱(250 mm×4.6 mm,5μm);流动相为乙腈-0.1%磷酸溶液(27∶73及40∶60);流速为1.0 ml/min;检测波长为241 nm;进样量为20μl;柱温为30℃;样品提取超声时间为20 min。结果伏立诺他浓度在24.66~295.92μg/ml范围内与峰面积呈良好的线性关系,r=0.999 9,检测限为10.07 ng/ml,其它方法学验证各项指标均良好。伏立诺他对高温与光照较稳定,其酸降解、碱降解、氧化降解产物和苯胺等有关物质与伏立诺他均有良好的分离。结论该方法灵敏度与准确度高,专属性强,可应用于伏立诺他的质量控制。 Objective To establish a high performance liquid chromatography method for detecting the content of Vorinostat. Methods Luna-Cls column(250 mm x 4.6 mm, 5 p.m) was used, with a mobile phase of acetonitrile-0.1% phosphate buffer (27:73 and 40: 60), and flow rate of 1.0 ml/min. The detection wavelength was 241 nm, the sample volumn was 20μl, and the column temperature was 30 ℃. The ultraphonic extract time of sample was 20 min. Results The concentration of Vorinostat showed good linearity with peak area in the range of 24.66 - 295.92 μg/ml, r = 0.999 9. The lowest determination limit was 10.07 ng/ml. The other methodology checking indicator were all well. Vorinostat was stable under high temperature and illumination, the degradation product of acid degradation, base degradation, oxidation degradation and the related substances such as aniline were all has high sensitivity and accuracy, good specificity, and can be separated well from Voriinostat. Conclusion The method used for quality control of Vorinostat.
作者 肖健
出处 《今日药学》 CAS 2012年第2期71-74,102,共5页 Pharmacy Today
基金 2011年福建省教育厅科技项目(编号:JB11295)
关键词 伏立诺他 高效液相色谱 有关物质 测定 Vorinostat high-performance liquid chromatography related substances determination.
  • 相关文献

参考文献5

二级参考文献31

  • 1谢沐风.如何建立高效液相色谱法测定有关物质的方法[J].中国医药工业杂志,2007,38(1):45-48. 被引量:63
  • 2李晓晖,李建勋,李世荣,修志龙,西野宪和.环肽类组蛋白去乙酰化酶抑制剂[J].化学进展,2007,19(5):762-768. 被引量:7
  • 3Sakajiri S,Kumagai T,Kawamata N,et al.Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines[J].Exp Hematol,2005,33(1):53-61.
  • 4Cohen LA,Marks PA,Rifkind RA,et al.Suberoylanilide hydroxamic acid (SAHA),a histone deacetylase inhibitor,suppresses the growth of carcinogen-induced mammary tumors[J].Anticancer Res,2002,22 (3):1497-1504.
  • 5Breslow R,Marks PA,Rifkind RA,et al.Novel potent inducers of terminal differentiation and methods of use thereof:WO,9307148[P].1993-04-15.(CA 1993,119:138765)
  • 6Stowell JC,Huot RI,Van Voast L.The synthesis of N-hydroxy-N'-phenyloctanediamide and its inhibitory effect on proliferation of AXC rat prostate cancer cells[J].J Med Chem,1995,38(8):1411-1413.
  • 7Sbardella EG,Massa S.A new facile and expeditious synthesis of N-hydroxy-N'-phenyloctanediamide,a potent inducer of terminal cytodifferentiation[J].Org Prep Proced Int,2001,33 (4):391-394.
  • 8Gediya LK,Chopra P,Purushottamachar P,et al.A new simple and high-yield synthesis of suberoylanilide hydroxamic acid and its inhibitory effect alone or in combination with retinoids on proliferation of human prostate cancer cells[J].J Med Chem,2005,48 (15):5047-5051.
  • 9CRISCIONE VD, WEINSTOCK MA. Incidence of cutaneous T-cell lymphoma in the United States, 1973 -2002 [ J]. Arch Dermatol, 2007,143 (7) :854 - 859.
  • 10FDA approves new drug for skin cancer, Zolinza[EB/OL], (2006 - 10 - 06). http ://www. fda. gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm 108758. htm.

共引文献15

同被引文献25

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部